DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Gaurav Jain - 3 Philip Morris - 2 Goldman Sachs - 2 Bonnie Herzog - 2 Herzog - 2 Kappa - 1 Leroy Seafood - 1 WestRock - 1
Top related locs:
U.S New York London Norwegian Austrian Russia East North Africa
Top related orgs:
Barclays - 3 Raiffeisen Bank - 1 U.S - 1 Mar - 1 Smurfit Kappa Barclays - 1 Kappa - 1 Seafood Barclays - 1 Leroy Seafood Group - 1

Search resuls for: "Gaurav Jain"


4 mentions found


☆ Barclays names three global stocks to buy for the next quarter, giving them major upside
  + stars: | 2024-03-12 | by ( Ganesh Rao | ) www.cnbc.com   time to read: +3 min
Barclays has named three European stocks — Smurfit Kappa , Leroy Seafood and Raiffeisen Bank — for investors to consider buying for the upcoming quarter. 7: Smurfit Kappa Barclays is bullish on paper packaging maker Smurfit Kappa with a £38.30 ($49.10) price target, indicating 16% upside potential. SKG-GB 1Y mountain Leroy Seafood Barclays also highlighted Leroy Seafood Group, a Norwegian seafood company. Raiffeisen Bank Barclays named Raiffeisen Bank International, an Austrian banking group, as another stock to own in the next quarter, giving it an upside potential of 35%. "Strabag deal improves credibility on Russia exit plan," Barclays analyst Krishnendra Dubey said in a note to clients on Mar.
Persons: Kappa, Leroy Seafood, WestRock, Gaurav Jain, Leroy, Krishnendra Dubey Organizations: Barclays, Raiffeisen Bank, U.S, Mar, Smurfit Kappa Barclays, Kappa, Seafood Barclays, Leroy Seafood Group, Raiffeisen Bank Barclays, Raiffeisen Bank International, Raiffeisen, Strabag Locations: London, New York, Norwegian, Austrian, U.S, Russia
☆ Analysts are getting bullish on these corporate earnings slated for release this week
  + stars: | 2023-10-16 | by ( Lisa Kailai Han | ) www.cnbc.com   time to read: +3 min
Another 10% of S & P 500 companies is due to report earnings this week, with Netflix and Tesla as major headliners. Against this backdrop, CNBC Pro screened for the S & P 500 companies reporting this week that have analysts the most excited, therefore raising their earnings estimates. Here's the criteria followed for the search: Slated to report earnings this week. The company is slated to report earnings Friday. Also making the cut was Philip Morris , which is scheduled to report earnings Thursday.
Persons: Nancy Tengler, Schlumberger, Morgan Stanley, Daniel Kutz, Philip Morris, Gaurav Jain, Goldman Sachs, Bonnie Herzog, Herzog, — CNBC's Michael Bloom Organizations: Netflix, Tesla, Investments, CNBC, CNBC Pro, Schlumberger, Barclays, American Express Locations: East, North Africa, U.S, Vegas Sands, Blackstone
☆ Investors want to know when Philip Morris' smoke-free shift will pay off
  + stars: | 2023-09-26 | by ( Christina Cheddar Berk | ) www.cnbc.com   time to read: +6 min
Anticipation should be building as Philip Morris prepares to bring iQOS back to the U.S. market. Philip Morris had partnered with Altria when iQOS was first launched in a handful of U.S. markets in 2019. Eventually, Philip Morris agreed to buy back the commercialization rights from Altria, and that deal is effective April 30, 2024. And this strategy is partly why, Herzog said, Philip Morris is one of Goldman's top picks. Last week, Philip Morris CEO Jacek Olczak spoke on X via ReutersPlus about its harm reduction efforts.
Persons: Philip, Goldman Sachs, Bonnie Herzog, Philip Morris, iQOS, Herzog, mgmt, Gaurav Jain, Jain, FactSet, Jacek Olczak, Jefferies, Owen Bennett, Bennett Organizations: Philip Morris International, Drug Administration, Altria, Barclays, Swedish Match, Bank of America, Rogue, Street Journal, Concordia, United Nations General Assembly Locations: U.S, Altria, New York
☆ Buy this fertilizer stock poised to rally nearly 50%, Barclays says
  + stars: | 2022-11-08 | by ( Samantha Subin | ) www.cnbc.com   time to read: +1 min
Barclays says investors should consider putting their money in Scotts Miracle-Gro , a pandemic-era beneficiary positioned to generate solid free cash flows ahead. "We expect SMG to deliver c$6-$8 FCF/share in the next three years from strong underlying US Consumer business and working capital adjustment," analyst Gaurav Jain wrote in his upgrade of the stock to an overweight rating. "This will help it to de-lever from the current high leverage and help guide upside." Monetization of the company's cannabis business — to which Barclays attributes zero value — could also provide further upside for the stock, he said. Barclays' unchanged $75 price target implies a 45% upside for the stock from Monday's close.
0 next >>
Total: 4